; and (B) if fentanyl is present as a cutting agent or in its pure form, may consider such presence as an aggravating factor at sentencing. (3) Better identification and reporting practices by medical examiners and coroners to identify fentanyl in an overdose mortality will help the States and the Federal Government to allocate resources more accurately. Those findings ought to be confidential but for any aggregate data released by the appropriate government agency. (4) Congress encourages States to expand training opportunities to first responders to administer naloxone. (5) Eliminating the civil liability of first responders administering naloxone would save lives and protect our emergency personnel. 3. Expansion of educational campaign grants (a) In general For each of fiscal years 2018 and 2019, the Director of the Centers for Disease Control and Prevention, in consultation with the Director of the Office of National Drug Control Policy, may make not more than $75,000,000 in grants to eligible grantees for the following purposes: (1) Expansion of educational efforts to prevent abuse of opiates including heroin. (2) Promotion of treatment and recovery of persons who abuse such substances. (3) Efforts to promote understanding of addiction as a chronic disease. (b) Eligible grantees A grant under this section may be made only to the following entities: (1) A State, with grants first being awarded to States with laws in effect that provide for immunity from civil liability for first responders and health professionals who administer naloxone in the course of their duty to counteract opiate overdoses. (2) A local government. (3) A nonprofit organization. (4) An organization that has received a grant under the Drug-Free Communities Act of 1997 to implement a comprehensive community-wide strategy that addresses a local drug crisis. (c) Amount of grants The amount of a grant under this section to an eligible grantee for a fiscal year may not be more than $100,000. (d) Authorization of appropriations To carry out this